Abstract
The case of a 54 year old patient suffering from gastrinoma (within a type I multiple endocrine neoplasm) is presented. In 1990, she underwent a surgical resection. Eight years later, she suffered from a pain in the left thigh. The 99mTc-MDP bone scintigraphy showed bone metastasis. The CT scan did not show any hepatic involvement and the scintigraphy with 111In-Pentetreotide verified bone metastasis of a neuroendocrine tumor as a single expression of the recidive. In this case, the utility of the scintigraphy with octreotide to facilitate the localization and extent of the neuroendocrine tumors is demonstrated.
MeSH terms
-
Adrenalectomy
-
Female
-
Femoral Neoplasms / diagnostic imaging
-
Femoral Neoplasms / radiotherapy
-
Femoral Neoplasms / secondary*
-
Gastrinoma / complications
-
Gastrinoma / diagnostic imaging
-
Gastrinoma / radiotherapy
-
Gastrinoma / secondary*
-
Humans
-
Hyperparathyroidism, Secondary / etiology
-
Liver / diagnostic imaging
-
Middle Aged
-
Multiple Endocrine Neoplasia Type 1 / diagnostic imaging*
-
Palliative Care
-
Pancreatectomy
-
Pancreatic Neoplasms / complications
-
Pancreatic Neoplasms / pathology*
-
Pancreatic Neoplasms / surgery
-
Radionuclide Imaging
-
Radiopharmaceuticals*
-
Somatostatin / analogs & derivatives*
-
Splenectomy
-
Zollinger-Ellison Syndrome / etiology
Substances
-
Radiopharmaceuticals
-
Somatostatin
-
pentetreotide